Toyobo Co (3101) AI Stock Analysis

• Market Cap: $100.54B
• Dividend Yield: 3.49%
• Average Volume (3M): 305.73K
• Price to Earnings (P/E): 35.4
• Beta (1Y): 0.58
• Revenue Growth: -0.62%
• EPS Growth: -25.56%
• Country: JP
• Employees: 10,668
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 14.55
• Shares Outstanding: 89,048,790
• 10 Day Avg. Volume: 223,990
• 30 Day Avg. Volume: 305,730
• PEG Ratio: -2.24
• Price to Book (P/B): 0.43
• Price to Sales (P/S): 0.20
• P/FCF Ratio: -5.00
• Enterprise Value/Market Cap: 3.57
• Enterprise Value/Revenue: 0.86
• Enterprise Value/Gross Profit: 3.62
• Enterprise Value/Ebitda: 10.60
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 62 Neutral
• Price Target: ¥1,191.00 ▲(4.02% Upside)

Toyobo Co's stock score is primarily influenced by its stable financial performance and positive technical indicators. The company's profitability challenges and high P/E ratio weigh on the valuation score. The absence of earnings call data and corporate events limits further insights.

Toyobo Co Business Overview & Revenue Model

Company Description

Toyobo Co., Ltd. is a diversified Japanese company primarily engaged in the manufacturing and sales of textiles, chemicals, and advanced materials. The company operates across several sectors, including polymers, biotechnology, and functional materials. Toyobo's core products include synthetic fibers, films, and various industrial materials, as well as medical and pharmaceutical products, catering to a wide range of industries such as automotive, electronics, and healthcare.

How the Company Makes Money

Toyobo generates revenue through a multi-faceted business model that includes the production and sale of high-performance materials and specialty chemicals. Key revenue streams include the sale of textiles, engineering plastics, and films used in packaging and electronics. Additionally, the company's biotechnology division contributes to earnings through the development and commercialization of pharmaceutical products and medical devices. Strategic partnerships with other companies in sectors such as automotive and electronics further enhance revenue opportunities, allowing Toyobo to leverage its technological expertise and innovation in developing new products tailored to market demands.

Toyobo Co Financial Statement Overview

Summary

Toyobo Co demonstrates steady revenue growth and efficient cost management but faces profitability challenges. The balance sheet shows moderate leverage and a balanced capital structure, yet generating shareholder returns remains weak. Cash flow challenges arise from high capital expenditures, affecting financial flexibility.

Income Statement

Toyobo Co has shown a stable revenue growth trend with a 1.87% increase in the latest year. The gross profit margin is robust at 22.99%, indicating effective production cost management. However, net profit margin is low at 0.47%, suggesting pressures on profitability. EBIT and EBITDA margins are moderate, reflecting consistent operational efficiency.

Balance Sheet

The debt-to-equity ratio stands at 1.34, indicating a moderate level of leverage. The equity ratio is 31.61%, suggesting a balanced capital structure. Return on equity is low at 1.03%, highlighting challenges in generating returns from shareholders' equity.

Cash Flow

The company has a negative free cash flow, impacting its financial flexibility. Operating cash flow covers net income well, with a ratio of 14.29, but the free cash flow to net income ratio is negative, reflecting high capital expenditures.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	419.77B	422.03B	414.26B	399.92B	375.72B	337.41B
Gross Profit	99.15B	97.06B	88.00B	85.01B	96.13B	90.37B
EBITDA	33.87B	32.05B	26.75B	20.99B	36.09B	25.96B
Net Income	2.79B	2.00B	2.46B	-655.00M	12.87B	4.20B
Balance Sheet
Total Assets	611.51B	617.80B	606.99B	588.91B	517.77B	491.19B
Cash, Cash Equivalents and Short-Term Investments	30.79B	28.58B	33.80B	60.70B	27.18B	34.70B
Total Debt	265.12B	261.07B	242.09B	225.17B	187.69B	182.92B
Total Liabilities	382.86B	385.75B	376.90B	367.48B	320.63B	302.55B
Stockholders Equity	193.44B	195.31B	197.03B	189.59B	194.88B	185.73B
Cash Flow
Free Cash Flow	0.00	-16.60B	-35.03B	-31.36B	-12.02B	7.53B
Operating Cash Flow	0.00	28.62B	21.59B	7.80B	17.10B	35.03B
Investing Cash Flow	0.00	-46.39B	-58.78B	-36.01B	-24.61B	-31.68B
Financing Cash Flow	0.00	10.49B	8.26B	61.30B	-1.73B	5.34B

Toyobo Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1145.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3101, the sentiment is Positive. The current price of 1145 is above the 20-day moving average (MA) of 1135.90, above the 50-day MA of 1127.46, and above the 200-day MA of 975.08, indicating a bullish trend. The MACD of 8.68 indicates Negative momentum. The RSI at 52.77 is Neutral, neither overbought nor oversold. The STOCH value of 35.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3101.

Toyobo Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4471	―	$89.23B	8.33	7.85%	4.05%	-16.01%	―
4008	―	¥65.60B	14.03	―	4.18%	0.32%	-43.10%
4369	―	¥94.63B	16.58	―	1.17%	71.39%	87.22%
4028	―	¥94.97B	8.85	―	4.84%	8.46%	74.58%
3101	―	$100.54B	35.43	―	3.49%	-0.62%	-25.56%
Sector *	―	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%

Toyobo Co Corporate Events

Toyobo Co. Shifts Sector Classification to Chemicals

Toyobo Co., Ltd. has announced a change in the sector classification of its stock from ‘Textiles & Apparels’ to ‘Chemicals’ on the Tokyo Stock Exchange Prime Market. This change, effective October 1, 2025, reflects the company’s growing net sales in chemical-related businesses, aligning with the criteria set by the Securities Identification Code Committee. This reclassification signifies Toyobo’s strategic shift and expanding focus on the chemicals sector, potentially impacting its market positioning and stakeholder interests.

The most recent analyst rating on (JP:3101) stock is a Hold with a Yen1050.00 price target. To see the full list of analyst forecasts on Toyobo Co stock, see the JP:3101 Stock Forecast page.

Toyobo Reports Profit Growth Despite Decline in Sales

Toyobo Co., Ltd. reported a decrease in net sales for the three months ended June 30, 2025, but saw significant increases in operating and ordinary profits, indicating improved operational efficiency. The company maintained its dividend forecast and expects a positive fiscal year ending March 31, 2026, with projected growth in net sales and profits, reflecting a strong market position and potential benefits for stakeholders.